bioRxivMicrobiologyPreprint
Aminoglycosides induce a bacterial senescent state that increases antibiotic tolerance in treatment-naïve cells
Abstract
1.Bacterial evolution of antibiotic resistance is facilitated by non-genetic resistance that increases drug tolerance, buying time for evolutionary innovation. Escherichia coli treated with aminoglycosides permanently lose the ability to divide within four hours, yet we discovered a majority of cells maintain membrane integrity and metabolic activity greater than two days post treatment - a bacterial senescent-like state. These cells, which we term zombies, exhibit dynamic gene expression and metabolomic profiles, even after irreversible exit from the cell cycle. Our data reveal zombies upregulate the phage shock protein pathway to maintain membrane integrity. Remarkably, though unable to form new colonies, zombies increase the antibiotic tolerance of treatment-naive cells, implying chemical communication. Chemical supplementation and genetic knockouts show that zombies communicate with treatment-naive cells by secreting indole. In summary, our study revealed a bacterial senescent-like state, induced by aminoglycosides, that decreases the antibiotic susceptibility of multiple bacterial species. Thus, E. coli zombies utilize paracrine signaling to promote non-genetic antibiotic tolerance.
- organism: E. coli
- assay: metabolomics
- assay: proteomics
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: genetic perturbation / CRISPR
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phage Paride hijacks bacterial stress responses to kill dormant, antibiotic-tolerant cells
E. Maffei, M. Burkolter, … A. Harms·bioRxiv·Jan 26, 2022
- Bacteria primed by antimicrobial peptides develop tolerance and persist
A. Rodriguez Rojas, D. Y. Baeder, … J. Rolff·bioRxiv·May 19, 2020
- Antimicrobial peptides can generate tolerance by lag and interfere with antimicrobial therapy
D. Sandin Garcia, J. Valle, … M. Torrent Burgas·bioRxiv·Jun 3, 2022
- Single-cell phenotypic characteristics of phenotypic resistance under recurring antibiotic exposure in Escherichia coli
S. Kollerova, L. Jouvet, … U. K. Steiner·bioRxiv·May 26, 2021
- A host-directed adjuvant resuscitates and sensitizes intracellular bacterial persisters to antibiotics
Kuan‐Yi Lu, Xiangbo Yang, … Brian P. Conlon·Nature MicrobiologyPeer-reviewed·Oct 10, 2025
- Decoupling the molecular versatility of aminoglycosides via drug or target modification enables community-wide antiphage defense
L. Kever, Q. Zhang, … J. Frunzke·bioRxiv·Feb 27, 2024